The browser you are currently using is not being supported by this website, please upgrade to a more recent browser for a better viewing experience.
Independent Adviser(s): Northington Partners (Rule 18)
Offer Date: 14/06/2013
Summary of transaction:
On 14 June 2013, EBOS Group Limited ("EBOS") held a special meeting of shareholders. At the meeting, EBOS shareholders approved the allotment of EBOS shares to Zuellig Group ("Zuellig") as part-consideration for EBOS' acquisition of Zuellig Healthcare Holdings Australia Pty Limited (Symbion).
The purchase price for the transaction was NZ$865 million which was to be paid to Zuellig via two components:
The issue of fully paid ordinary shares in EBOS (such that Zuellig would hold 40% of the total shares on issue in EBOS on completion of the transaction - valued at approximately NZ$498 million at the time).
A cash payment of NZ$367 million.